Skip to main content

Table 1 Outcomes, follow-up periods and types of participants

From: Early (≤ 30 Days), Late (31–360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis

Studies Outcomes reported Follow-up time period (years) Types of participants Types of DES
Banning et al. [6] Early (acute and sub-acute) and late ST 1 Left main and triple vessel disease PES
Jain et al. [7] Early (acute and sub-acute) and late ST 1 CAD ZES
Jiang et al. [8] Early, late and very late ST 2 CAD DES
Kereiakes et al. [9] Early (acute and sub-acute) and late ST 1 CAD EES, PES
Nakamura et al. [10] Early, late and very late ST 3 CAD + hemodialysis SES
Silber et al. [11] Early, late and very late 2 CAD ZES
Simek et al. [12] Early, late and very late 3 CAD EES, SES, PES
  1. Early stent thrombosis: 0–30 days
  2. Late stent thrombosis: 31–360 days
  3. Very late stent thrombosis: > 360 days
  4. ST stent thrombosis, DES drug-eluting stents, CAD coronary artery disease, PES paclitaxel-eluting stents, EES everolimus-eluting stents, SES sirolimus-eluting stents, ZES zotarolimus-eluting stents